OGEN
Oragenics IncCompany with tickers: OGEN
CIK
1174940
CUSIP
684023609
Shares Outstanding
4,511,957
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $2,255,927 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Research & Development | $645,470 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Operating Income | $-2,255,927 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Net Income | $-2,201,243 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | $-0.51 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Diluted) | $-0.51 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |